RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Champaign, IL · Chicago, IL · +21 more sites